×
Real-Time Telehealth Versus Face-to-Face Management for Patients With PTSD in Primary Care: A Systematic Review and Meta-Analysis PDF
$ 40.00
Real-Time Telehealth Versus Face-to-Face Management for Patients With PTSD in Primary Care: A Systematic Review and Meta-Analysis PDF quantity
$ 40.00
×
Comparison of Clinical Characteristics and Comorbidity in Schizophrenia Patients With and Without Obsessive-Compulsive Disorder: Schizophrenic and OC Symptoms in Schizophrenia. PDF
$ 40.00
Comparison of Clinical Characteristics and Comorbidity in Schizophrenia Patients With and Without Obsessive-Compulsive Disorder: Schizophrenic and OC Symptoms in Schizophrenia. PDF quantity
$ 40.00
×
A 6-Month, Multicenter, Open-Label Evaluation of Beaded, Extended-Release Carbamazepine Capsule Monotherapy in Bipolar Disorder Patients With Manic or Mixed Episodes PDF
$ 40.00
A 6-Month, Multicenter, Open-Label Evaluation of Beaded, Extended-Release Carbamazepine Capsule Monotherapy in Bipolar Disorder Patients With Manic or Mixed Episodes PDF quantity
$ 40.00
×
A Survey of Medically Self-Sabotaging Behaviors Among Perpetrators of Partner Violence PDF
$ 40.00
A Survey of Medically Self-Sabotaging Behaviors Among Perpetrators of Partner Violence PDF quantity
$ 40.00
×
The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial PDF
$ 40.00
The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial PDF quantity
$ 40.00
×
Mirtazapine: Efficacy and Tolerability in Comparison With Fluoxetine in Patients With Moderate to Severe Major Depressive Disorder PDF
$ 40.00
Mirtazapine: Efficacy and Tolerability in Comparison With Fluoxetine in Patients With Moderate to Severe Major Depressive Disorder PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
